Korean regulators shut down Samsung Pharma manufacturing after finding additives, false records
South Korea’s health regulator has suspended Samsung Pharmaceutical’s manufacturing operations until mid-February after the agency learned that a production manager was tasked with responsibilities of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.